170 related articles for article (PubMed ID: 35023296)
1. Restoring erectile function by combined treatment with JNK inhibitor and HDAC inhibitor in a rat model of cavernous nerve injury.
Lee J; Cho MC; Son H; Kim SW
Andrology; 2022 May; 10(4):758-766. PubMed ID: 35023296
[TBL] [Abstract][Full Text] [Related]
2. Restoration of erectile function by a combination of antiapoptosis by JNK inhibitor and preservation of smooth muscle or endothelium by hepatocyte growth factor in a rat model of cavernous nerve injury.
Kim SW; Lee J; Oh S; Son H; Cho MC
Prostate; 2022 Jan; 82(1):49-58. PubMed ID: 34609772
[TBL] [Abstract][Full Text] [Related]
3. Chronic treatment with a combination of hepatocyte growth factor and JNK inhibitor ameliorates cavernosal veno-occlusive dysfunction: a rat model of cavernous nerve injury.
Lee J; Son H; Kim SW; Cho MC
J Sex Med; 2023 May; 20(6):749-755. PubMed ID: 37037785
[TBL] [Abstract][Full Text] [Related]
4. The effects of single versus combined therapy using LIM-kinase 2 inhibitor and type 5 phosphodiesterase inhibitor on erectile function in a rat model of cavernous nerve injury-induced erectile dysfunction.
Cho MC; Lee J; Park J; Oh S; Chai JS; Son H; Paick JS; Kim SW
Asian J Androl; 2019; 21(5):493-500. PubMed ID: 30829289
[TBL] [Abstract][Full Text] [Related]
5. Combination of LIM-kinase 2 and Jun Amino-terminal Kinase Inhibitors Improves Erectile Function in a Rat Model of Cavernous Nerve Injury.
Kim SW; Lee J; Park J; Chai JS; Oh S; Paick JS; Cho MC
Urology; 2019 Sep; 131():136-143. PubMed ID: 31202856
[TBL] [Abstract][Full Text] [Related]
6. Rectification of cavernosal fibrosis and veno-occlusive dysfunction by administration of suberoylanilide hydroxamic acid in a rat model of cavernosal nerve injury: Comparison with a PDE5 inhibitor.
Cho MC; Lee J; Son H; Kim SW
Andrology; 2021 Mar; 9(2):720-727. PubMed ID: 33064925
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Jun N-terminal Kinase Improves Erectile Function by Alleviation of Cavernosal Apoptosis in a Rat Model of Cavernous Nerve Injury.
Park J; Chai JS; Kim SW; Paick JS; Cho MC
Urology; 2018 Mar; 113():253.e9-253.e16. PubMed ID: 29203189
[TBL] [Abstract][Full Text] [Related]
8. Combination Therapy with a JNK Inhibitor and Hepatocyte Growth Factor for Restoration of Erectile Function in a Rat Model of Cavernosal Nerve Injury: Comparison with a JNK Inhibitor Alone or Hepatocyte Growth Factor Alone.
Lee J; Kim SW; Cho MC
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884500
[TBL] [Abstract][Full Text] [Related]
9. Valproic acid prevents penile fibrosis and erectile dysfunction in cavernous nerve-injured rats.
Hannan JL; Kutlu O; Stopak BL; Liu X; Castiglione F; Hedlund P; Burnett AL; Bivalacqua TJ
J Sex Med; 2014 Jun; 11(6):1442-51. PubMed ID: 24636283
[TBL] [Abstract][Full Text] [Related]
10. Role of inhibiting LIM-kinase2 in improving erectile function through suppression of corporal fibrosis in a rat model of cavernous nerve injury.
Park J; Cho SY; Park K; Chai JS; Son H; Kim SW; Paick JS; Cho MC
Asian J Androl; 2018; 20(4):372-378. PubMed ID: 29516877
[TBL] [Abstract][Full Text] [Related]
11. Role of Jun amino-terminal kinase (JNK) in apoptosis of cavernosal tissue during acute phase after cavernosal nerve injury.
Song WH; Son H; Kim SW; Paick JS; Cho MC
Asian J Androl; 2018; 20(1):50-55. PubMed ID: 28440265
[TBL] [Abstract][Full Text] [Related]
12. Chronic administration of LIMK2 inhibitors alleviates cavernosal veno-occlusive dysfunction through suppression of cavernosal fibrosis in a rat model of erectile dysfunction after cavernosal nerve injury.
Park J; Son H; Chai JS; Kim SW; Paick JS; Cho MC
PLoS One; 2019; 14(3):e0213586. PubMed ID: 30870492
[TBL] [Abstract][Full Text] [Related]
13. Restoration of erectile function by suppression of corporal apoptosis, fibrosis and corporal veno-occlusive dysfunction with rho-kinase inhibitors in a rat model of cavernous nerve injury.
Cho MC; Park K; Kim SW; Paick JS
J Urol; 2015 May; 193(5):1716-23. PubMed ID: 25444982
[TBL] [Abstract][Full Text] [Related]
14. Dual Strategy With Oral Phosphodiesterase Type 5 Inhibition and Intracavernosal Implantation of Mesenchymal Stem Cells Is Superior to Individual Approaches in the Recovery of Erectile and Cavernosal Functions After Cavernous Nerve Injury in Rats.
Martínez-Salamanca JI; Zurita M; Costa C; Martínez-Salamanca E; Fernández A; Castela A; Vaquero J; Carballido J; Angulo J
J Sex Med; 2016 Jan; 13(1):1-11. PubMed ID: 26755080
[TBL] [Abstract][Full Text] [Related]
15. Buyang Huanwu Decoction Ameliorates Damage of Erectile Tissue and Function Following Bilateral Cavernous Nerve Injury.
Ye MY; Zhao F; Ma K; Yao LJ; Zhou K; Ma JX; Lyu BD; Xu ZB
Chin J Integr Med; 2023 Sep; 29(9):791-800. PubMed ID: 35679003
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of Cavernosal Fibrosis and Erectile Function by Lysyl Oxidase Inhibition in a Rat Model of Cavernous Nerve Injury.
Wan ZH; Li GH; Guo YL; Li WZ; Chen L; Zhang YJ
J Sex Med; 2018 Mar; 15(3):304-313. PubMed ID: 29502979
[TBL] [Abstract][Full Text] [Related]
17. Chronic administration of udenafil, a selective phosphodiesterase type 5 inhibitor, promotes erectile function recovery in an animal model of bilateral cavernous nerve crush injury.
Lee CH; Kim HS; Goo MJ; Kang KK; Ahn BO; Kim SH; Yang DY
J Sex Med; 2011 May; 8(5):1330-40. PubMed ID: 21366883
[TBL] [Abstract][Full Text] [Related]
18. Restoration of Cavernous Veno-Occlusive Function through Chronic Administration of a Jun-Amino Terminal Kinase Inhibitor and a LIM-Kinase 2 Inhibitor by Suppressing Cavernous Apoptosis and Fibrosis in a Rat Model of Cavernous Nerve Injury: A Comparison with a Phosphodiesterase Type 5 Inhibitor.
Cho MC; Lee J; Park J; Kim SW
World J Mens Health; 2021 Jul; 39(3):541-549. PubMed ID: 32777863
[TBL] [Abstract][Full Text] [Related]
19. Involvement of Rho-Kinase/LIM Kinase/Cofilin Signaling Pathway in Corporal Fibrosis after Cavernous Nerve Injury in Male Rats.
Song SH; Park K; Kim SW; Paick JS; Cho MC
J Sex Med; 2015 Jul; 12(7):1522-32. PubMed ID: 25923835
[TBL] [Abstract][Full Text] [Related]
20. P144, A TGF-β1 antagonist peptide, synergizes with sildenafil and enhances erectile response via amelioration of cavernosal fibrosis in diabetic rats.
Li WJ; Wang H; Zhou J; Li B; Zhang J; Lu M; Wang Z
J Sex Med; 2013 Dec; 10(12):2942-51. PubMed ID: 24134744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
